Precision Medicine Trials for Cancer: A New Era

NCI is designing smaller, quicker, and smarter clinical trials that incorporate the principal tenets of precision medicine. Source link

Two Small RNAs, Often Missing from Cancer Cells, May Suppress Tumors

Two small RNAs that are frequently deleted from cancer cells may help suppress tumors by interacting with RAS proteins, a...

FDA Approves Cobimetinib as Part of Drug Combination for Advanced Melanoma

The FDA has approved the targeted drug cobimetinib, in combination with another targeted therapy, to treat patients with advanced melanoma...

Controls and Credibility Are Essential for Testing

The information gathered from clinical trials and clinical research is often used to help verify details and to help continue...

New Drug for Pediatric Neuroblastoma Shows Promise in Preclinical Studies

An international research team has identified a possible new treatment target for pediatric neuroblastoma and is planning an early-stage clinical...

Checking In on Cancer Checkpoint Inhibitors

NCI’s Dr. James Gulley discusses cancer checkpoint inhibitors, their impact on patient care, and future directions for these therapies. Source...

What's New on NCI’s Websites?

NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to...

Quit Smoking – Using Clear Language To Achieve Your Goal

Words have enormous power to help, to damage, to confuse or to clarify. Out tone can mean we are being...

Cancer Can Lead to Financial Hardship, Study Confirms

A substantial number of working-age cancer survivors report material or psychological financial hardship associated with their cancer. Source link